Valor Management LLC

Institutional investor · Portfolio as of Q1 2026

Q1 2026 biggest moves

Reported value$55.1M → $181M

  • BTGOBTGO

    BitGo

    New listing

    57% of portfolio

  • THARTHAR

    CANTON STRATEGIC HOLDINGS IN

    New

    2.0% of portfolio

2 changes in all

Top Holdings5 positions

Checking export access…
Activity:
BTGO

BitGo Holdings, Inc.

12.5M$103.2M57.0%$8.230.00%
1 qtr
New
Unranked
BWAY
BWAY
ADR

BrainsWay Ltd.

5.3M$70.6M39.1%$5.71+132.58%
6 qtrssince 2024-Q4
Unchanged
0
THAR

CANTON STRATEGIC HOLDINGS IN

1.1M$3.5M2.0%$3.27-13.76%
1 qtr
New
64
HRMY

Harmony Biosciences Holdings, Inc.

117,130$3.3M1.8%$42.64-34.31%
18 qtrssince 2021-Q4
Unchanged
0
BIOA

BioAge Labs, Inc.

13,105$229,2060.1%$20.80-15.91%
7 qtrssince 2024-Q3
Unchanged
0
$180.9M
AUM
5
Positions
Q1 2026
Filing
HI rating · 1.5/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2024-Q4$249,155,410-47.5019020692%
2025-Q1$240,576,897-3.44303701854%
2025-Q2$238,134,281-1.01531611325%
2025-Q3$67,337,124-71.7230447808%
2025-Q4$55,101,559-18.1706082368%
2026-Q1$180,883,163228.2723144%
Activity profile
$ moved · Q1'26
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q40%1-4Q0%1-2Y20%2Y+40%

Valor Management LLC manages $180.9M across 5 positions as of Q1 2026. Top holdings: BTGO (57.0%), BWAY (39.1%), THAR (2.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Top holdings by portfolio weight

Total AUM$181M
BTGO57.05%
BWAY39.05%
THAR1.96%
HRMY1.81%
BIOA0.13%

Portfolio allocation by GICS sector

Sectors1
Healthcare100.00%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L18
Conviction71
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used